← Verified COAs & $/mg for this compound
Retatrutide Research Dosing Reference
Also known as: LY3437943, Triple Agonist (GLP-1/GIP/GCGR), Reta
Studied in NEJM Phase 2 human trials (Jastreboff et al., PMID: 37366315). Subjects started at 1–2 mg once weekly and titrated every 4 weeks.
Once every 7 days SubQ (titrated gradually every 4 weeks)
Phase 2/3 trials titrate from 1–2 mg/wk up to 4–8 mg/wk (max 12 mg/wk) over 24–48 weeks.
SubQ injection once weekly
NEJM Phase 2 RCTs & ongoing TRIUMPH Phase 3 human trials
~6 days (~144 hours) terminal half-life enabling steady once-weekly dosing
A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.
All U-100: 100 units = 1 mL. 10 doses in the vial at the low end (1 doses at the high end).
Save Retatrutide to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.
Retatrutide supplier & $/mg comparison.
At a Glance · 2026 FDA / 503A / WADA / Evidence Profile
What is a GLP-1 Agonist?
A molecule that mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates blood sugar, slows gastric emptying, and reduces appetite. Semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) are GLP-1 agonists. These are peptides, but they are marketed and prescribed as pharmaceutical drugs.
EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Retatrutide is not FDA approved for human use (unless specified above). This information does not constitute medical advice.
Overview
Retatrutide is a triple hormone receptor agonist developed by Eli Lilly. It simultaneously activates GLP-1, GIP, and glucagon receptors — the first of its kind. Phase 2 trials showed unprecedented weight loss results (up to 24% of body weight), making it the most effective obesity medication in development.
Mechanisms of Action
- Activates GLP-1 receptor — appetite suppression, glucose control
- Activates GIP receptor — enhanced insulin secretion, fat metabolism
- Activates glucagon receptor — increased energy expenditure, fat oxidation
- Triple mechanism produces synergistic weight loss effects
Research Protocols
Metabolic, Hepatic & Incretin Safety Biomarker Panel (Retatrutide)
Quantify visceral fat mobilization, insulin resistance reversal, hepatic steatosis (MASH) clearance, and pancreatic/renal safety during metabolic protocols.
HbA1c & Fasting Insulin (HOMA-IR)
Day 0 + Wk 6–8Why track at baseline: Measures baseline hyperinsulinemia and 90-day glycemic load prior to incretin or lipolytic initiation.
Week 6–8 check: Track rapid drop in Fasting Insulin (often 30%–50% reduction by Week 6–8) and normalizing HbA1c.
ALT, AST & GGT Liver Enzymes
Day 0 + Wk 6–8Why track at baseline: Dual/triple agonists (Retatrutide, Mazdutide, Pemvidutide) mobilize 65%–80% of intrahepatic triglycerides.
Week 6–8 check: Confirm progressive reduction in ALT/AST (<25 U/L) as hepatic steatosis clears.
ApoB, Triglycerides & Advanced Lipid Panel
Day 0 + Wk 6–8Why track at baseline: Quantifies atherogenic particle burden and VLDL triglyceride export before weight loss.
Week 6–8 check: Expect 20%–40% triglyceride drop and significant ApoB improvement alongside visceral fat loss.
Serum Lipase, Amylase & eGFR / Cystatin C
Day 0 + Wk 6–8Why track at baseline: Essential safety screen for subclinical pancreatic inflammation and hydration/renal filtration.
Week 6–8 check: Ensure Lipase stays within reference range and eGFR remains stable with adequate electrolyte hydration.
Related Studies
Phase 2 trial of retatrutide in adults with obesity showed dose-dependent weight loss up to 24.2% at 48 weeks with the 12mg dose. The triple agonist (GLP-1/GIP/glucagon) demonstrated unprecedented efficacy for obesity treatment.
Limitations: Phase 2 only — Phase 3 trials ongoing; longer-term safety data needed; some GI side effects
Community Outcomes
Community Data Coming Soon
Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!
Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.
Important Warnings
- •Currently in Phase 3 trials — not yet FDA approved
- •Expected side effects similar to other GLP-1 agonists (nausea, GI issues)
- •Long-term safety data not yet available
- •Only available through clinical trials currently
Where to get Retatrutide, baseline labs & clinician oversight.
Ascension Peptides (US Vials)
MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.
SwissChems & Limitless Biotech
Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).
Superpower Labs & 503A Telehealth
Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.
Where to buy Retatrutide: best verified price
Prices checked Nov 11, 2026 · sorted by $/mg · RUO
- 1. Elite Research USA — $3.75/mg (60mg vial, sold as “ER-RT”, $225.00)
- 2. Ascension Peptides — $4.17/mg (30mg vial, sold as “R-30”, $125.00)
- 3. Peptyes — $5.00/mg (30mg vial, sold as “GLP-3 (R)” (vendor code name; compound per COA identity result), $150.00)
Where is the cheapest place to buy Retatrutide?
As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Elite Research USA at $3.75/mg (60mg vial, sold as “ER-RT”, $225.00). We compared 7 US suppliers with live, checked prices.
How much does Retatrutide cost per mg?
Verified US domestic prices currently range from $3.75/mg to $6.67/mg depending on supplier and vial size. Larger vials usually lower the $/mg.
How are these prices verified?
Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.
Is Retatrutide approved for human use?
Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.
All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet
Peptide Reconstitution & U-100 Syringe Cheat Sheet
Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.
Related Peptides
More metabolic peptides
Semaglutide
Semaglutide is a GLP-1 receptor agonist that mimics the horm...
Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It rep...
Liraglutide
Liraglutide is an FDA-approved GLP-1 receptor agonist used f...
AOD-9604 (hGH Frag 176-191)
AOD-9604 is a modified fragment of human growth hormone (hGH...
5-Amino-1MQ
5-Amino-1MQ is a small molecule that inhibits NNMT (Nicotina...
Vendor vs vendor: price per mg
Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.
- Ascension vs SwissChems (3 shared compounds)
- Elite vs SwissChems (3 shared compounds)
- Elite vs Ascension (26 shared compounds)
- Protide vs SwissChems (3 shared compounds)
- Protide vs Ascension (6 shared compounds)
- Ameano vs SwissChems (3 shared compounds)
- Ameano vs Ascension (4 shared compounds)
- Swift vs Ascension (23 shared compounds)
- BioLongevity vs Ascension (16 shared compounds)
- Peptyes vs SwissChems (3 shared compounds)
- Peptyes vs Elite (20 shared compounds)
- Peptyes vs Swift (17 shared compounds)
- Peptyes vs Pure (17 shared compounds)
- Peptyes vs Ascension (20 shared compounds)
Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →
Common questions
How many peptides are in the database?
100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.
Where can I compare peptide prices?
Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.